# ZINPLAVA

NDC: 0006-3025
Generic name: bezlotoxumab
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20161021

FDA application: BLA761046

## Active ingredients

- BEZLOTOXUMAB: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-3025"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-3025
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f479bfe-2bfa-4cc5-9aee-1357364480b0